Company Profile

LadRx Corporation (AKA: CytRx Corporation~SynthRx, Inc)
Profile last edited on: 12/14/2023      CAGE: 47KM5      UEI: R8LAMV13KEV4

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

11726 San Vicente Bulvard Suite 650
Los Angeles, CA 90049
   (310) 826-5648
Location: Multiple
Congr. District: 33
County: Los Angeles

Public Profile

Formerly known as CytRx Corporation, LadRx Corporationis engaged in the development and commercialization of pharmaceutical-related products and services primarily involving human therapeutics focused on high-value critical-care therapies. The Phase III clinical trials for the treatment of acute sickle cell crisis. LadRx is also developing FLOCOR for acute respiratory disorders and has plans to expand its development for other vascular disorders such as shock and stroke over time. LadRx is also currently engaged in research in the areas of infectious disease, gene and drug delivery, vaccines, and animal feed additives

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 1 NIH $222,048
Project Title: Transition-State Inhibitors of Fatty Acid Synthase
1998 2 NIH $600,190
Project Title: Evaluation Of CRL-1072 For Treatment Of Mycobacterium Avium

Key People / Management

  Stephen Snowdy -- Chief Executive Officer

  John Y Caloz -- CFO, Treasurer Senior VP & Corporate Secretary

  Martin R Emanuele

  Chinnaswamy Jagannath

  Felix Kratz -- Senior VP, Drug Development

  Steven A Kriegsman -- Chairman & CEO

  Daniel Levitt -- Chief Medical Officer

  Molly Carey Poarch -- Global & U.S. Head of Corporate Communications

  Jerry W Skiles

  Terri Stevens -- Chief Business Officer